Abstract
Lipid-induced insulin resistance is associated with inflammatory state in epidemiological studies. However, it is still unclear whether the activation of NF-κB, a pivotal transcription factor of inflammation, plays a crucial role in mediating skeletal muscle insulin resistance. This study addressed what was the role of NF-κB in lipid-induced insulin resistance and whether NF-κB activation was sufficient to cause insulin resistance in C2C12 myotubes. A 16 h exposure of myotubes to palmitate reduced net insulin-stimulated glucose uptake by 48%, GLUT4 translocation by 52%, Akt phosphorylation by 54%, induced a 1.8-fold increase in insulin-stimulated insulin receptor substrate (IRS) phosphorylation, and doubled NF-κB activation. Myotubes transfected with NF-κB p65 siRNA for 24 h and followed by a treatment with palmitate for 16 h efficiently blocked NF-κB activation, and prevented the detrimental effects of palmitate on the metabolic actions of insulin. Transfection of myotubes with I-κBα siRNA for 24 h also led to a twofold induction of NF-κB activation, and reduced net insulin-stimulated glucose uptake by 30%, GLUT4 translocation by 35%, Akt phosphorylation by 31%, induced a 0.7-fold increase in insulin-stimulated IRS phosphorylation. These findings suggest that NF-κB overexpression per se is sufficient to impair insulin sensitivity and palmitate-induced insulin resistance is mediated by NF-κB in skeletal muscle cells.
Similar content being viewed by others
References
J.P. Wilding, Diabet. Med. 24, 934–945 (2007)
J.D. McGarry, Science 258, 766–770 (1992)
P. Brassard, F. Frisch, F. Lavoie, D. Cyr, A. Bourbonnais, S.C. Cunnane, B.W. Patterson, R. Drouin, J.P. Baillargeon, A.C. Carpentier, J. Clin. Endocrinol. Metab. 93, 837–844 (2008)
A. Carpentier, S.D. Mittelman, B. Lamarche, R.N. Bergman, A. Giacca, G.F. Lewis, Am. J. Physiol. 276, E1055–E1066 (1999)
S.E. Shoelson, L. Herrero, A. Naaz, Gastroenterology 132, 2169–2180 (2007)
A. Festa Jr., R. D’Agostino, R.P. Tracy, S.M. Haffner, Diabetes 51, 1131–1137 (2002)
C. Winzer, O. Wagner, A. Festa, B. Schneider, M. Roden, D. Bancher-Todesca, G. Pacini, T. Funahashi, A. Kautzky-Willer, Diabetes Care 27, 1721–1727 (2004)
E. Park, V. Wong, X. Guan, A.I. Oprescu, A. Giacca, J. Endocrinol. 195, 323–331 (2007)
J. Reid, A.I. MacDougall, M.M. Andrews, Br. Med. J. 2, 1071–1074 (1957)
P.J. Barnes, M. Karin, N. Engl. J. Med. 336, 1066–1071 (1997)
S. Schreiber, Gut 44, 309–310 (1999)
M. Karin, Y. Ben-Neriah, Annu. Rev. Immunol. 18, 621–663 (2000)
U.J. Lee, S.R. Choung, K.V. Prakash, E.J. Lee, M.Y. Lee, Y.J. Kim, C.W. Han, Y.C. Choi, Mol. Biol. Rep. 35, 291–298 (2008)
S.I. Itani, N.B. Ruderman, F. Schmieder, G. Boden, Diabetes 51, 2005–2011 (2002)
S. Sinha, G. Perdomo, N.F. Brown, R.M. O’Doherty, J. Biol. Chem. 279, 41294–41301 (2004)
M. Jove, A. Planavila, J.C. Laguna, M. Vazquez-Carrera, Endocrinology 146, 3087–3095 (2005)
E. Polkinghorne, Q. Lau, G.J. Cooney, E.W. Kraegen, M.E. Cleasby, Am J. Physiol. Endocrinol. Metab. 294, E316–E325 (2008)
P. Barma, S. Bhattacharya, A. Bhattacharya, R. Kundu, S. Dasgupta, A. Biswas, S. Bhattacharya, S.S. Roy, S. Bhattacharya, Biochim. Biophys. Acta 1792, 190–200 (2009)
Y. Wei, J.R. Sowers, S.E. Clark, W. Li, C.M. Ferrario, C.S. Stump, Am. J. Physiol. Endocrinol. Metab. 294, E345–E351 (2008)
T. Ogihara, T. Asano, H. Katagiri, H. Sakoda, M. Anai, N. Shojima, H. Ono, M. Fujishiro, A. Kushiyama, Y. Fukushima, M. Kikuchi, N. Noguchi, H. Aburatani, Y. Gotoh, I. Komuro, T. Fujita, Diabetologia 47, 794–805 (2004)
M. Yuan, N. Konstantopoulos, J. Lee, L. Hansen, Z.W. Li, M. Karin, S.E. Shoelson, Science 293, 1673–1677 (2001)
M.C. Arkan, A.L. Hevener, F.R. Greten, S. Maeda, Z.W. Li, J.M. Long, A. Wynshaw-Boris, G. Poli, J. Olefsky, M. Karin, Nat. Med. 11, 191–198 (2005)
P.P. Hommelberg, J. Plat, R.C. Langen, A.M. Schols, R.P. Mensink, Am. J. Physiol. Endocrinol. Metab. 296, E114–E120 (2009)
A.A. Beg, W.C. Sha, R.T. Bronson, D. Baltimore, Genes Dev. 9, 2736–2746 (1995)
M. Pasparakis, T. Luedde, M. Schmidt-Supprian, Cell Death Differ. 13, 861–872 (2006)
D. Cai, M. Yuan, D.F. Frantz, P.A. Melendez, L. Hansen, J. Lee, S.E. Shoelson, Nat. Med. 11, 183–190 (2005)
J.K. Kim, Y.J. Kim, J.J. Fillmore, Y. Chen, I. Moore, J. Lee, M. Yuan, Z.W. Li, M. Karin, P. Perret, S.E. Shoelson, G.I. Shulman, J. Clin. Invest. 108, 437–446 (2001)
H.L. Pahl, Oncogene 18, 6853–6866 (1999)
P. Plomgaard, K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J.R. Zierath, B.K. Pedersen, Diabetes 54, 2939–2945 (2005)
B. Feve, J.P. Bastard, Nat. Rev. Endocrinol. 5, 305–311 (2009)
J. Spranger, A. Kroke, M. Mohlig, K. Hoffmann, M.M. Bergmann, M. Ristow, H. Boeing, A.F. Pfeiffer, Diabetes 52, 812–817 (2003)
L. Osborn, S. Kunkel, G.J. Nabel, Proc. Natl Acad. Sci. USA 86, 2336–2340 (1989)
T. Bouwmeester, A. Bauch, H. Ruffner, P.O. Angrand, G. Bergamini, K. Croughton, C. Cruciat, D. Eberhard, J. Gagneur, S. Ghidelli, C. Hopf, B. Huhse, R. Mangano, A.M. Michon, M. Schirle, J. Schlegl, M. Schwab, M.A. Stein, A. Bauer, G. Casari, G. Drewes, A.C. Gavin, D.B. Jackson, G. Joberty, G. Neubauer, J. Rick, B. Kuster, G. Superti-Furga, Nat. Cell Biol. 6, 97–105 (2004)
D. Melisi, J. Niu, Z. Chang, Q. Xia, B. Peng, S. Ishiyama, D.B. Evans, P.J. Chiao, Mol. Cancer Res. 7, 624–633 (2009)
L. Pickersgill, G.J. Litherland, A.S. Greenberg, M. Walker, S.J. Yeaman, J. Biol. Chem. 282, 12583–12589 (2007)
N.C. Andrews, D.V. Faller, Nucleic Acids Res. 19, 2499 (1991)
X. Wu, H. Motoshima, K. Mahadev, T.J. Stalker, R. Scalia, B.J. Goldstein, Diabetes 52, 1355–1363 (2003)
Acknowledgment
The study was supported by the Natural science foundation of Guangdong Province, China (Grant No. 7001282).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, J., Wu, W., Li, D. et al. Overactivation of NF-κB impairs insulin sensitivity and mediates palmitate-induced insulin resistance in C2C12 skeletal muscle cells. Endocr 37, 157–166 (2010). https://doi.org/10.1007/s12020-009-9283-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-009-9283-y